Quarterly Update to the End-Stage Renal Disease Prospective Payment System (ESRD PPS
The purpose of this Change Request (CR) is to provide instructions for discontinuing the Transitional Drug Add-on Payment Adjustment (TDAPA) effective April 1, 2024, for Healthcare Common Procedure Coding System (HCPCS) code J0879 Injection, difelikefalin, 0.1 microgram, (for ESRD on dialysis).
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 25, 2024
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.